Mr. Subhrajyoti Banerjee, Griffith University, Australia
Subhrajyoti Banerjee is a dynamic and interdisciplinary biomedical researcher from West Bengal, India, currently pursuing a Ph.D. in Human Biology at Griffith University, Australia. His academic and research trajectory demonstrates a consistent focus on cutting-edge therapeutics, particularly the use of exosome-based techniques in neuroregeneration and brain cancer diagnostics. Subhrajyoti brings a unique blend of molecular biology, bioengineering, and translational medicine to his work, making notable contributions to both diagnostic and therapeutic research. With multiple international peer-reviewed publications, collaborations with hospitals and biotech labs, and hands-on expertise in nanomedicine and immunotherapy, he has established himself as a rising figure in biomedical science. His strong academic record, combined with impactful research in cancer biology and neurological repair, positions him as a promising candidate for significant contributions to global healthcare innovation.
Publication Profile:
Google Scholar
Orcid
✅ Strengths for the Award:
-
Interdisciplinary Expertise: Subhrajyoti has deep knowledge in biotechnology, biomedical engineering, and molecular biology, spanning diagnostics, therapeutics, and regenerative medicine.
-
Cutting-Edge Research: His research on exosomes for brain cancer diagnosis and cell-free therapies using glial extracellular vesicles aligns with global priorities in personalized and non-invasive medicine.
-
Strong Publication Record: He has multiple peer-reviewed publications, including articles in journals like Extracellular Vesicle, Synlett, and Chemistry – A European Journal.
-
Hands-on Technical Proficiency: Skilled in molecular biology (PCR, ELISA), bioinformatics (NGS, mutagenesis), nanotechnology, and in-silico drug development.
-
Academic Excellence: Consistently high CGPAs in all degrees (up to 9.4/10), with top performance in national-level exams like GATE (2020 & 2024).
-
Early Research Maturity: Significant achievements already at the pre-doctoral and early Ph.D. stage, with collaboration across institutes and real-world applications.
🛠️ Areas for Improvement:
-
Patent Filing and Commercial Translation: While the research is innovative, translating it into patents, startups, or licensed technologies would amplify real-world impact.
-
International Collaborations: Though currently pursuing a PhD abroad, broader international co-authorship or research consortium involvement could strengthen global outreach.
-
Leadership Roles: Opportunities to mentor junior researchers or lead funded projects would further demonstrate leadership potential in the scientific community.
🎓 Education:
Subhrajyoti Banerjee’s academic journey reflects an unwavering commitment to biomedical innovation. He is currently enrolled in a Ph.D. program in Human Biology at Griffith University (2025–Present), focusing on therapeutic applications of olfactory glial extracellular vesicles. He earned his Master of Technology in Biomedical Engineering (2022–2024) from IIEST Shibpur, achieving an outstanding CGPA of 9.4 and conducting research on exosome-based early diagnostics for brain cancer. Prior to this, he completed an M.Sc. in Biotechnology (2018–2020) from Techno India University with a CGPA of 9.01, where he explored antibody mimetics in cancer immunotherapy. His undergraduate studies in Biotechnology (2015–2018) at MAKAUT gave him a strong foundation in genetic engineering, molecular biology, and medical biotechnology. His academic path illustrates both breadth and depth across biomedical disciplines, from basic science to clinical translation.
💼 Professional Experience:
Subhrajyoti’s professional experience is deeply rooted in interdisciplinary biomedical research. As an M.Tech researcher at IIEST (2022–2024), he led projects involving nanoparticle-based theragnostics and collaborated with medical institutions for brain cancer diagnostics. His innovative work involved synthesizing electromagnetic and autofluorescent nanoparticles for tumor detection. Previously, he served as a Research Assistant and Teaching Aid (2019–2020) at Techno India University, where he contributed to cancer immunotherapy studies under Dr. Malavika Bhattacharya. His skills encompass both in-silico and in-vitro techniques, including ELISA, flow cytometry, cell culture, and computational modeling. Additionally, he has coordinated sample collection with hospitals and performed biomarker analysis for exosomal studies. This hands-on lab experience, combined with translational research initiatives, underscores his ability to bridge the gap between laboratory innovation and real-world medical application.
🏅 Awards & Honors:
Subhrajyoti Banerjee has received multiple recognitions highlighting his academic excellence and research potential. He qualified in GATE 2024 and GATE 2020, two of India’s most competitive national-level examinations, affirming his expertise in engineering and life sciences. His work was honored with the 1st Prize for Poster Presentation at the BIRAC 5th Annual Symposium in 2020, reflecting innovation in translational biotech. He also presented at the 4th Regional Science & Technology Congress (2020) and university-level symposia, showcasing his work in both diagnostics and therapeutic biotechnology. These accolades illustrate his proactive engagement with the academic and scientific community. His contributions in nanomedicine, exosome biology, and bioinformatics make him a strong contender for research-based recognitions.
🔬 Research Focus:
Subhrajyoti Banerjee’s research centers on exosome-based diagnostics and therapeutics, with a deep emphasis on brain cancer and neuroregeneration. His ongoing Ph.D. explores olfactory glia-derived extracellular vesicles for cell-free, regenerative therapies. He previously developed liquid biopsy approaches using exosomal biomarkers for early detection of glioblastoma. His expertise spans nanoparticle engineering, molecular docking, antibody mimetics, and cell-line studies, aiming to bridge lab research with clinical solutions. Subhrajyoti’s interdisciplinary approach draws from molecular biology, pharmacology, and bioinformatics, positioning his work at the forefront of personalized medicine and neuro-oncology. His commitment to translational science is evident through multi-institutional collaborations and his ability to apply emerging technologies like NGS, spectroscopy, and computational biology for solving real-world medical problems.
📚 Publications Top Notes:
-
🧠 Exploring emerging concepts of exosomes for brain cancer diagnosis and therapeutics – Extracellular Vesicle (2024)
-
🏥 Internet of Medical Things and Healthcare 4.0: Trends and future directions – JEEEMI (2024)
-
⚗️ Reaction under Ball-Milling: Solvent- and Metal-Free Synthesis of Tetrahydroquinoline Derivatives – Synlett (2024)
-
🧪 Room temperature palladium-catalyzed synthesis of unsymmetrical diamide scaffolds – Journal of Molecular Structure (2024)
-
🍋 Comparative study of therapeutic properties of lemons – International Journal of Herbal Medicine (2023)
-
🔬 Reusable Iron-Copper Catalyzed Cross-Coupling for N-Arylamides – Chemistry – A European Journal (2025)
-
💻 Computational Design of Antibody Mimetics for Enhanced Cancer Immunotherapy – Techno India University (2020)
-
🧬 Antibody Mimetic for Immunotherapy Against Cancer – University Dissertation (2019)
🔍 Conclusion:
Subhrajyoti Banerjee exhibits all the hallmarks of a rising star in biomedical research: a strong foundation in theory, excellence in lab techniques, impactful research on exosomes and nanomedicine, and a forward-thinking approach to cancer diagnostics and therapeutics.
His ability to navigate between basic science and translational application, and a growing international profile with Griffith University, makes him a highly suitable candidate for the Best Researcher Award. With continued focus on innovation and scientific leadership, he is well-positioned to become a significant contributor to the global biomedical research community.